Claudia C. Giannotta

Turin, 10126, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Specific HLA-DRB1 Alleles Associate With Anti-Caspr1 and Anti-CNTN1 Autoantibodies in Autoimmune Nodopathies.

Specific HLA-DRB1 Alleles Associate With Anti-Caspr1 and Anti-CNTN1 Autoantibodies in Autoimmune Nodopathies.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: June 23, 2026

Targeting a novel metabolic vulnerability of non-small cell lung cancer to fatty acid oxidation surmounts chemoresistance.

Targeting a novel metabolic vulnerability of non-small cell lung cancer to fatty acid oxidation surmounts chemoresistance.

Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy

Published: December 13, 2025

VEGF as a Relapse Marker and an Intensity of Disease Marker in Patients Affected by POEMS Syndrome Treated With Autologous Peripheral Blood Stem Cell Transplantation.

VEGF as a Relapse Marker and an Intensity of Disease Marker in Patients Affected by POEMS Syndrome Treated With Autologous Peripheral Blood Stem Cell Transplantation.

Journal: Hematological oncology

Published: December 09, 2024

From Cancer to Immune Organoids: Innovative Preclinical Models to Dissect the Crosstalk between Cancer Cells and the Tumor Microenvironment.

From Cancer to Immune Organoids: Innovative Preclinical Models to Dissect the Crosstalk between Cancer Cells and the Tumor Microenvironment.

Journal: International journal of molecular sciences

Published: September 14, 2024

Genomic and immune determinants of resistance to daratumumab-based therapy in relapsed refractory multiple myeloma.

Genomic and immune determinants of resistance to daratumumab-based therapy in relapsed refractory multiple myeloma.

Journal: Blood cancer journal

Published: February 13, 2024

Genomic and immune determinants of resistance to anti-CD38 monoclonal antibody-based therapy in relapsed refractory multiple myeloma.

Genomic and immune determinants of resistance to anti-CD38 monoclonal antibody-based therapy in relapsed refractory multiple myeloma.

Journal: medRxiv : the preprint server for health sciences

Published: December 18, 2023

Correction to: Frequency and clinical correlates of anti-nerve antibodies in a large population of CIDP patients included in the Italian database.

Correction to: Frequency and clinical correlates of anti-nerve antibodies in a large population of CIDP patients included in the Italian database.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: November 26, 2023

Prospective open-label trial with rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy not responding to conventional immune therapies.

Prospective open-label trial with rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy not responding to conventional immune therapies.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: October 21, 2023

Regular assessment of serum vascular endothelial growth factor levels to monitor POEMS syndrome.

Regular assessment of serum vascular endothelial growth factor levels to monitor POEMS syndrome.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: June 29, 2023

Vγ9Vδ2 T-cell immunotherapy in blood cancers: ready for prime time?

Vγ9Vδ2 T-cell immunotherapy in blood cancers: ready for prime time?

Journal: Frontiers in immunology

Published: February 16, 2023

The immune suppressive tumor microenvironment in multiple myeloma: The contribution of myeloid-derived suppressor cells.

The immune suppressive tumor microenvironment in multiple myeloma: The contribution of myeloid-derived suppressor cells.

Journal: Frontiers in immunology

Published: November 18, 2022

Immune dysfunctions affecting bone marrow Vγ9Vδ2 T cells in multiple myeloma: Role of immune checkpoints and disease status.

Immune dysfunctions affecting bone marrow Vγ9Vδ2 T cells in multiple myeloma: Role of immune checkpoints and disease status.

Journal: Frontiers in immunology

Published: October 18, 2022

Showing 1-12 of 28

Last Updated: 09/26/2026